MedPath

Hepatic Transplantation Registry

Recruiting
Conditions
Identify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing Patient Factors
Registration Number
NCT05944042
Lead Sponsor
Methodist Health System
Brief Summary

The objective is to provide a mechanism to store information regarding the demographic characteristics; pre-, intra-, and post-transplant laboratories; treatment strategies; complications; and outcomes in patients undergoing hepatic transplantation.

Detailed Description

This study will be conducted at Methodist Dallas Medical Center and include data from hepatic transplant patients beginning in January 2019 and continuing until statistical significance is achieved. Patients will be identified based on ICD-10 procedure codes which are only available post-discharge in the EMR. Data will be collected once patient is discharged and no additional procedures are necessary. All cases meeting the inclusion criteria are expected to be included in this study

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Age ≥18 years Submitted to hepatic transplantation (Current Procedural Terminology® code 47135
Exclusion Criteria
  • Does not meet inclusion criteria specified in 3.1

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Need for prospective registry studies to determine patient factors to measure long-term survivial2 years

As the demand for liver transplantation continues to grow, there is a need to identify more accurate predictive models of transplant risk. Therefore, prospective registry studies are needed to monitor and evaluate new and existing patient factors associated with long-term survival.

Methods of storing information on demographics of transplant patients2 yrs

The objective is to provide a mechanism to store information regarding the demographic characteristics; pre-transplant, intra-transplant, and post-transplant laboratories; treatment strategies; complications; and outcomes in patients undergoing hepatic transplantation.

Secondary Outcome Measures
NameTimeMethod
Total Number and Description of Study Sites/Total Number of Subjects Projected2 yrs

This study will be conducted at Methodist Dallas Medical Center and include data from hepatic transplant patients beginning in January 2019 and continuing until statistical significance is achieved. Patients will be identified based on International classification of Disease (ICD-10) procedure codes which are only available post-discharge in the EMR. Data will be collected once patient is discharged and no additional procedures are necessary. All cases meeting the inclusion criteria are expected to be included in this study.

Trial Locations

Locations (1)

Methodist Dallas Medical Center

🇺🇸

Dallas, Texas, United States

Methodist Dallas Medical Center
🇺🇸Dallas, Texas, United States
Colette N Ndjom, MS
Contact
214-947-4680
mhsirb@mhd.com
Loretta W Bedell, MPH
Contact
217-947-4681
mhsirb@mhd.com
Alejandro Mejia, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.